Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
accommodate, Advent, aircraft, Alabama, Almeida, analyzed, annum, Bendamustine, Bielefeld, Bloomington, calendar, Chairman, charter, country, cover, criteria, deficiency, Delaware, dialyzer, dismissed, disposition, employment, enacted, entirety, EPA, event, exercise, Exhibit, extension, German, Germany, GmbH, Grover, Halle, identification, Indiana, involuntary, Kelley, Lake, largely, lowest, met, minimized, MSA, noncash, Norepinephrine, Opelika, Polish, population, prejudice, President, prorated, qualified, relevant, Round, Ruble, Russian, salary, select, sequential, sequentially, sourcing, subsection, subsided, text, TSA, usage, Warburg, withheld, Zloty
Removed:
assumed, biopharmaceutical, contracted, internationally, investigation, opioid, packaging, recently, remote
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view